Life Time Group Holdings, Inc. (LTH) Stock News

Life Time Group Holdings (LTH) is positioned as a more attractive value investment compared to Airbnb (ABNB). LTH has a Zacks Rank of #2 (Buy) with a Value grade of B, featuring a forward P/E of 23.46 and P/B ratio of 2.76. ABNB has a Zacks Rank of #3 (Hold) with a Value grade of F, showing a forward P/E of 32.13 and P/B ratio of 12.86, indicating it is significantly more expensive on traditional valuation metrics.

Duluth Holdings reported quarterly earnings of $0.06 per share, beating consensus estimates of a loss of $0.05, representing a 220% earnings surprise. The company posted revenues of $121.39 million, surpassing estimates by 1.92%, though down from $131.72 million year-ago. Shares have gained 74% year-to-date versus the S&P 500's 12% gain. However, the stock holds a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market.

Law firm Kirby McInerney LLP is investigating Hims & Hers Health following an FTC lawsuit alleging the company engaged in deceptive privacy practices by sharing customers' sensitive medical information with third-party advertisers including Meta Platforms. The announcement triggered a 14.73% stock price decline on July 29, 2026.

Aimei Health Technology Co., Ltd. announced the termination of its Business Combination Agreement with United Hydrogen Group Inc. on July 7, 2026, due to failure to close the transaction by the outside date specified in the agreement. The company expressed confidence in identifying future transaction opportunities.

Amerant Investments announced the appointment of Ricardo Sucre as Head of International Wealth Management Business Development. Sucre brings over 20 years of experience from leading financial institutions including Morgan Stanley and Bolton Global Capital. The appointment reflects Amerant's strategic focus on expanding its international wealth management platform and attracting experienced financial advisors to its integrated banking and investment services model.

Law firm Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims against Wealthfront Corporation following the company's disappointing Q3 2026 earnings report. Wealthfront reported net deposits of $1.6 billion, down significantly from $4.4 billion in the prior year, causing the stock to decline 16.84% to $10.47 per share on January 13, 2026. The firm is seeking shareholders who suffered losses to join the investigation.

Pomerantz LLP is investigating potential securities fraud claims against Wealthfront Corporation following significant stock price declines. The company's stock fell 16.84% on January 13, 2026, after reporting decreased asset outflows, and again fell 14.35% on June 5, 2026, after revealing a 69% year-over-year decline in net deposits and margin compression from startup expenses.

Universal Health Realty Income Trust (NYSE:UHT) announced that its Board of Trustees voted to increase the quarterly dividend by $0.005, with a new dividend of $0.75 per share payable on June 30, 2026 to shareholders of record as of June 22, 2026.

A securities fraud investigation into Wealthfront Corporation continues as the company faces significant challenges. In Q3 2025, Wealthfront reported $208 million in net deposit outflows, a sharp reversal from $874 million in inflows the prior year. The company's stock declined 16.8% following CEO David Fortunato's disclosure that he personally owns 95.1% of the home-lending business and may revisit its ownership structure. Further declines occurred in June 2026 when Q1 2026 results revealed a 69% year-over-year decline in net deposits and margin compression from startup expenses.

The Law Offices of Frank R. Cruz is investigating Wealthfront Corporation for potential federal securities law violations. The investigation follows significant net deposit outflows of $208 million in Q3 2025 and a 69% year-over-year decline in Q1 2026 deposits to $554 million. Stock price declines of 16.8% and 14.35% occurred following earnings announcements in January and June 2026, respectively, prompting a class action lawsuit on behalf of affected shareholders.

StealthGas Inc. reported Q1 2026 net income of $15.9 million ($0.43 EPS), a 24% increase from the previous quarter, with revenues of $42.8 million. The company strengthened its liquidity to $131.2 million and secured approximately 55% of fleet days for the remainder of 2026 under period charters. Three vessel sales were completed or announced, generating approximately $26 million in proceeds. The company maintains an unlevered balance sheet with all vessels unencumbered.

Universal Health Services, Inc. (NYSE:UHS) announced that its Board of Directors approved a cash dividend of $0.20 per share payable on June 18, 2026 to shareholders of record as of June 8, 2026.

TORONTO , May 21, 2026 /CNW/ - Grey Wolf Animal Health Corp. (TSXV: WOLF ) ("Grey Wolf" or the "Company"), a Canadian diversified health company, today announced financial results for the three months ended March 31, 2026. Highlights Revenue for the quarter increased year over year by 10.5% to $8.8 million. Gross profit increased year over year by 13.5% to $4.7 million for the quarter. Adjusted EBITDA 1 increased year over year by 16.6% to $1.5 million for the quarter. Introducing a 5-year financial target to organically double Adjusted EBITDA 1 by the end of 2030. "We posted a solid first quarter for both revenue and Adjusted EBITDA," said Angela Cechetto, Chief Executive Officer. "Our Pharmacy business grew organically by 8.8% to $5.6 million due to an increase in sales of compounded products. Meanwhile, our Animal Health revenue grew by 13.8% to $3.1 million year-over-year resulting from an increase in sales of established products, new products introduced during the prior year and an increase in commission revenue. Adjusted EBITDA 1 for the quarter increased year-over-year by 16.6% to $1.5 million as a result of higher revenue and gross profits. During 2026, we will continue to advance our growth strategy by investing in key initiatives to support future scale, including the development of a new facility, implementation of an ERP system and continued investment in personnel." Ms. Cechetto continued, "Our five-year financial goals are grounded in a commitment to invest in our people, facilities and processes. As a result of these investments, we have set a target to organically double Adjusted EBITDA 1 by the end of 2030. We are also actively pursuing acquisition opportunities to meaningfully augment this organic growth plan over the same horizon." Key Financial Data and Comparative Results Three months ended Mar 31, 2026 Mar 31, 2025 Revenue $8,753,736 $7,921,835

Law firm Bragar Eagel & Squire is investigating GE HealthCare Technologies for potential securities law violations following the company's April 29, 2026 earnings announcement. GE HealthCare missed Q1 2026 consensus EPS estimates ($0.99 vs. $1.05 expected) and reduced full-year guidance to $4.80-$5.00 from $4.95-$5.15, citing a PDx supplier issue. The stock declined 13% ($9.01 per share) on the news.